Microvascular angina and inappropriate pain perception as the main mechanisms of cardiac syndrome X;Dławica mikronaczyniowa i zaburzenia percepcji bólu jako główne składowe patogenetyczne kardiologicznego zespołu X

Folia Cardiologica

Volumn 10, Issue 5, 2003, Pages 553-561

  Rogacka, Dorota ^a   Wysocki, Henryk ^a  

^a Klinika Intensywnej Terapii Kardiologicznej   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

TRIMETAZIDINE;

ANGINA PECTORIS; DISEASE ACTIVITY; EDITORIAL; ELECTROCARDIOGRAM; HUMAN; NOCICEPTION; PAIN THRESHOLD; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; SYNDROME X; THORAX PAIN;

EID: 0344513847     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (73)

1. Panting J.R., Gatehause P.D, Yang G.Z., Grothues F. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N. Engl. J. Med. 2002; 346: 1948-1953.
2. Kaski J.C., Rosano G.M., Collins P., Nihoyannopoulos P., Maseri A., Poole-Wilson P. Syndrome X: clinical characteristics and left ventricular function - a long term follow-up study. Am. J. Coll. Cardiol. 1995; 25: 807-814.
3. Sullivan A.K., Holdright D., Wright C.A. Chest pain in women: Clinical investigative and prognostic features. BMJ 1994; 308: 883-886.
4. Panza J., Laurienzo M., Curiel R. i wsp. Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography. J. Am. Coll. Cardiol. 1997; 29: 293-301.
5. Reaven G.M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
6. Reaven G.M. Syndrome X: Is one enough? Am. Heart J. 1994; 127: 1439-1442.
7. Perin C., Pacini G., Giunti S., Comune M., Conte M.R., Cassader M., Pagano G. Microvascular angina (cardiological syndrome X) per se is not associated with hyperinsulinaemia or insulin resistance. Eur. J. Clin. Invest. 2000; 30: 481-486.
8. Radice M., Giudici V., Marinelli G. Long-term follow-up in patients with positive exercise test and angiographically normal coronary arteries (syndrome X). Am. J. Cardiol. 1995; 75: 620-621.
9. Kemp H.G., Kronmal R.A., Vlietstra R.E. Coronary Artery Surgery Study. Seven year survival of patients with normal or near normal coronary arteriograms: A CASS registry study. J. Am. Coll. Cardiol. 1986; 7: 479-483.
10. Kemp H.G., Vokanos P.S., Cohn P.F., Gorlin R. The anginal syndrome associated with normal coronary arteriograms. Am. J. Cardiol. 1973; 54: 735-742.
11. Epstein S.E., Cannon III R.O., Bonow R.O. Exercise testing in patients with microvascular angina. Circulation 1991; supl. III: III-73-III-76.
12. Lanza G.A., Manzoli A., Pasceri V. i wsp. Ischemic-like ST-segment changes during Holter monitoring in patients with angina pectoris and normal coronary arteries but negative exercise testing. Am. J. Cardiol. 1997; 79: 1-6.
13. Cannon R.O., Bonow R.O., Bacharach S.L. i wsp. Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries and abnormal vasodilator reserve. Circulation 1985; 71: 218-226.
14. Anselmi M., Golia G., Marino P. Comparison of left ventricular function and volumes during transesophageal atrial pacing combined with two-dimentional echocardiography in patients with syndrome X, atherosclerotic coronary artery disease, and normal subjects. Am. J. Cardiol. 1997; 80: 1261-1265.
15. Fragasso G., Rossetti F., Dosio F. i wsp. High prevalence of the thallium-201 reverse redistribution phenomenon in patients with syndrome X. Eur. Heart J. 1996; 17: 1482-1487.
16. Kao C.H., Wang S.J., Ting C.T., Chen Y.T. Tc-99m Sestamibi Myocardial SPECT in syndrome X. Clin. Nucl. Med. 1996; 21: 280-283.
17. Camici P., Marraccini P., Lorenzoni R. i wsp. Coronary hemodynamics and myocardial metabolism in patients with syndrome X: Response to pacing stress. J. Am. Coll. Cardiol. 1991; 17: 1461.
18. Rosano G.M., Kaski J.C., Arie S. i wsp. Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur. Heart J. 1996; 17: 1175-1180.
19. Buchtial S.D., den Hollander J.A., Merz C.N. i wsp. Abnormal myocardial phosphorus-31 nuclear resonance spectroscopy in women with chest pain but normal coronary arteriograms. N. Engl. J. Med. 2000; 23: 829-835.
20. Rogacka D., Guzik P., Wysocki H. i wsp. Kardiologiczny zespół X. Monitorowanie EKG metoda Holtera, dipirydamolowa echokardiografia obciazeniowa i technetowa scyntygrafia perfuzyjna mieśnia sercowego u pacjentów z kardiologicznym zespołem X. Kardiol. Pol. 1999; 51: 293-299.
21. Chauhan A., Mullins P.A., Thuraisingham S.I. i wsp. Abnormal cardiac pain perception in syndrome X. J. Am. Coll. Cardiol. 1994; 24: 329-335.
22. Frober O., Arendt-Nielsen L., Bak P., Funch-Jensen P., Bagger J.P. Pain perception and brain evoked potentials in patients with angina despite normal coronary angiograms. Heart 1996; 75: 436-441.
23. Shapiro L.M., Crake T., Poole-Wilson P.A. Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? Clinical observation during cardiac cataterization. BMJ 1988; 296: 170-171.
24. Cannon III R.O., Quyyumi A.A., Schenke W.H. Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J. Am. Coll. Cardiol. 1990; 16: 1359-1362.
25. Turiel M., Galassi A.R., Glazier J.J., Kaski J.C., Meseri A. Pain threshold and tolerance in women with syndrome X and women with stable angina pectoris. Am. J. Cardiol. 1987; 6: 503-507.
26. Rosen S.D., Paulesu E., Wise R., Camici P. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart 2002; 87: 513-519.
27. Rosen S.D., Paulesu E., Nihoyannopoulos P. i wsp. Silent ischaemia as a central problem: regional brain activation compared in silent and painful myocardial ischaemia. Ann. Intern. Med. 1996; 124: 939-949.
28. Lanza G.A., Crea F. The complex link between brain and heart in cardiac syndrome X. Heart 2002; 88: 328-330.
29. 123I]-metaiodobenzylguanidine myocardial scyntigraphy. Circulation 1997; 96: 821-826.
30. Lanza G.A., Sestitio A., Pristipino S. i wsp. Spinal cord stimulation in patients with refractory anginal pain and normal coronary arteries. Ital. Heart J. 2001; 2: 25-30.
31. Maseri A., Crea F., Kaski J.C., Crake T. Mechanism of angina pectoris in syndrome X. J. Am. Coll. Cardiol. 1991; 17: 499-506.
32. Lanza G.A. Abnormal cardiac nerve function in syndrome X. Herz 1999; 24: 97-106.
33. Inobe Y., Kugiyama K., Moruta E. i wsp. Role of adenosine in pathogenesis of syndrome X: assessment with coronary hemodynamic measurement and thallium-201 myocardial single-proton emission computed tomography. J. Am. Coll. Cardiol. 1996; 28: 890-896.
34. Ely S.W., Berne R.M. Protective effects of adenosine in myocardial ischemia. Circulation 1992; 85: 893-904.
35. Crea F., Pupita G., Galassi A.R. i wsp. Role of adenosine in pathogenesis of anginal pain. Circulation 1990; 81: 164-172.
36. Lagerqvist B., Sylven C., Waldenstrom A. Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms. Br. Heart J. 1992; 68: 282-285.
37. Montorsi P., Fabbiocchi F., Loaldi A. i wsp. Coronary adrenergic hyperactivity in patients with syndrome X and abnormal electrocardiogram at rest. Am. J. Cardiol. 1991; 68: 1698-1727.
38. Rosano G., Ponikowski P., Adamopoulos S. i wsp. Abnormal autonomic control of the cardiovascular system in syndrome X. Am. J. Cardiol. 1994; 73: 1174-1179.
39. Camici P., Marracini P., Gistri R. i wsp. Adrenergically mediated coronary vasoconstriction in patients with syndrome X. Cardiovasc. Drugs Ther. 1994; 8: 221-226.
40. Egashira K., Inou T., Hirooka Y., Yamada A., Taheshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N. Engl. J. Med. 1993; 328: 1659-1664.
41. Zeiher A.M., Krause T., Schachinger V., Minners J., Moser E. Impaired endothelium dependent vasodilation of the coronary resistance vessels is associated with exercise-induced myocardial ischaemia. Circulation 1995; 91: 2345-2352.
42. Cannon R.O., Epstein S.E. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am. J. Cardiol. 1988; 61: 1338-1343.
43. Cannon R.O., Camici P.G., Epstein S. Pathophysiological dilemma of syndrome X. Circulation 1992; 85: 883-892.
44. Chauhan A., Mullins P.A., Petch M.C. i wsp. Is coronary flow reserve in response to papaverine really normal in syndrome X. Circulation 1994; 89: 1998-2004.
45. Lanza G.A., Luscher T.F., Pasceri V. i wsp. Effects of atrial pacing on arterial and coronary sinus endothelin-1 levels in syndrome X. Am. J. Cardiol. 1999; 84: 1187-1191.
46. Gaspardone A., Ferri C., Crea F. i wsp. Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: potential link between cardiac and metabolic syndrome X. J. Am. Coll. Cardiol. 1998; 32: 2031-2034.
47. Rosano G., Collins P., Kaski J. i wsp. Syndrome X in women is associated with estrogen deficiency. Eur. Heart J. 1995; 16: 610-614.
48. Rosano G., Peteres N., Poole-Wilson P. i wsp. 17-β-estradiol therapy lessens angina in postmenopausal women with syndrome X. Am. J. Coll. Cardiol. 1996; 28: 1500-1505.
49. Kaski J.C., Elliott P.E., Salomone O. i wsp. Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br. Heart J. 1995; 74: 620-624.
50. Piatti P.M., Fragasso G., Lucilla. D. i wsp. Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries. Am. J. Coll. Cardiol. 1999; 34: 1452-1460.
51. Boger RH., Bode-Boger S.M., Szuma A. i wsp. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842-1847.
52. Cooke J.P. Does ADMA cause endothelial dysfunction? Arterioscler. Thromb. Vasc. Biol. 2000; 20: 2032-2037.
53. Piatti P., Fragasso G., Monti L.D. i wsp. Acute intravenous L-arginine infusion decreases endotheli-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. Circulation 2003; 28: 429-436.
54. + pump in patients with cardiac syndrome X. Clin. Scien. 1999; 97: 369-375.
55. Webb S.C., Poole-Wilson P.A. Potassium exchange in the human heart during atrial pacing and myocardial ischaemia. Br. Heart J. 1986; 55: 554-559.
56. + transport in skeletal muscle. Physiol. Rev. 1986; 66: 542-580.
57. Botker H.E., Sonne H.S., Frobert O., Andreasen F. Enhanced exercise-induced hyperkalemia in patients with syndrome X. J. Am. Coll. Cardiol. 1999; 33: 1056-1061.
58. Poole-Wilson P.A. Potassium and the heart. Clin. Endocrin. Met. 1984; 13: 249-268.
59. Richter J.K., Bradley L.A., Castell D.O. Esophageal chest pain: current controversies in pathogenesis, diagnosis, and therapy. Ann. Intern. Med. 1989; 110: 66-78.
60. Cannon R.O., Cattau E.L., Yakshe P.N. Coronary flow reserve, esophageal motility and chest pain in patients with angiographically normal arteries. Am. J. Med. 1990; 88: 217-222.
61. Chauhan A., Petch M.C., Schofield P.M. Cardio-oesophageal reflux in humans as a mechanism for "link angina". Eur. Heart J. 1996; 17: 407-413.
62. Kaski J.C., Garcia V.F. Therapeutic options for the management of patients with cardiac syndrome X. Eur. Heart J. 2001; 22: 283-293.
63. Lanza G.A., Manzoli A., Bia E., Crea F., Maseri A. Acute effects of nitrates on exercise testing in patients with syndrome X. Circulation 1994; 90: 2695-2700.
64. Cannon R.O., Watson R.M., Rosing D.R. i wsp. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. Am. J. Cardiol. 1985; 56: 242-246.
65. Elliot P., Krzyzanowska-Dickinson K., Kaski J.C. i wsp. Effect of oral aminophilline in patients with angina and normal coronary arteriograms (cardiac syndrome X). Heart 1997; 77: 523-526.
66. Cannon R.O., Quyyumi A., Mincemoyer R. i wsp. Imipramine in patients with chest pain despite normal coronary angiograms. N. Engl. J. Med. 1994; 330: 1411-1417.
67. Botker H.E., Sonne H., Schmitz O. i wsp. Effects of doxazosin on exercise-induced angina pectoris, St-segment depression, and insulin sensitivity in patients with syndrome X. Am. J. Cardiol. 1998; 82; 1352-1356.
68. Cox I.D., Hann M., Kaski J.C. Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms. Eur. Heart J. 1998; 19: 250-254.
69. Sellier P., Audouin P., Payen B., Duong T.C., Corona P., Ourbak P. Acute effects of trimetazidine evaluated by exercise testing. Eur. J. Clin. Pharmacol. 1987; 33: 205-207.
70. Sellier P., Harpey C., Corona P. i wsp. Chronic effects of trimetazidine on ergometric parameters in effort angina. Cardiovasc. Drugs Ther. 1990; supl. 4: 822-823.
71. Detry J.M., Sellier P., Pennaforte S. i wsp. Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Br. J. Clin. Pharmac. 1994; 37: 279-288.
72. Rogacka D., Guzik P., Wykretowicz A., Rzeźniczak J., Dziarmaga M., Wysocki H. Effects of Trimetazidine on clinical symptoms and exercise tolerance in patients with syndrome X - a preliminary study. Coron. Artery Dis. 2000; 11: 171-177.
73. Nalbantgil S., Altinti A., Yilmaz H., i wsp. The effect of trimetazidine in the treatment of microvascular angina. Int. J. Angiol. 1999; 8: 40-43.